194 related articles for article (PubMed ID: 18823560)
21. Matrix metalloproteinase-2 polymorphism is associated with prognosis in prostate cancer.
dos Reis ST; Villanova FE; Andrade PM; Pontes J; de Sousa-Canavez JM; Sañudo A; Antunes AA; Dall'oglio MF; Srougi M; Moreira Leite KR
Urol Oncol; 2010; 28(6):624-7. PubMed ID: 19117773
[TBL] [Abstract][Full Text] [Related]
22. Single nucleotide polymorphisms in the NOS2 and NOS3 genes are associated with exhaled nitric oxide.
Dahgam S; Nyberg F; Modig L; Naluai AT; Olin AC
J Med Genet; 2012 Mar; 49(3):200-5. PubMed ID: 22368302
[TBL] [Abstract][Full Text] [Related]
23. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population.
Kallel A; Sbaï MH; Sediri Y; Abdessalem S; Mourali MS; Feki M; Mechmeche R; Jemaa R; Kaabachi N
Cytokine; 2013 Dec; 64(3):646-51. PubMed ID: 24095258
[TBL] [Abstract][Full Text] [Related]
25. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus.
Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD
Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551
[TBL] [Abstract][Full Text] [Related]
26. The T-786C NOS3 polymorphism in Alzheimer's disease: association and influence on gene expression.
Venturelli E; Galimberti D; Lovati C; Fenoglio C; Scalabrini D; Mariani C; Forloni G; Bresolin N; Scarpini E
Neurosci Lett; 2005 Jul; 382(3):300-3. PubMed ID: 15925107
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
28. Combination of polymorphisms in the beta2-adrenergic receptor and nitric oxide synthase 3 genes increases the risk for hypertension.
Misono M; Maeda S; Iemitsu M; Nakata Y; Otsuki T; Sugawara J; Zempo H; Yoshizawa M; Miyaki A; Kuno S; Matsuda M; Ajisaka R
J Hypertens; 2009 Jul; 27(7):1377-83. PubMed ID: 19373110
[TBL] [Abstract][Full Text] [Related]
29. [Arterial blood pressure variations: homocysteine and nitric oxide synthase gene polymorphisms (NOS3)].
Rodríguez Esparragón FJ; Rodríguez Pérez JC; Macías Reyes A; Hernández Trujillo Y; González Leiza M; Caballero Hidalgo A
Nefrologia; 2006; 26(5):559-63. PubMed ID: 17117898
[TBL] [Abstract][Full Text] [Related]
30. Combined analysis of multiple mRNA markers by RT-PCR assay for prostate cancer diagnosis.
Neves AF; Araújo TG; Biase WK; Meola J; Alcântara TM; Freitas DG; Goulart LR
Clin Biochem; 2008 Oct; 41(14-15):1191-8. PubMed ID: 18640109
[TBL] [Abstract][Full Text] [Related]
31. NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes.
Zineh I; Beitelshees AL; Haller MJ
Diabetes Care; 2007 Mar; 30(3):689-93. PubMed ID: 17327342
[TBL] [Abstract][Full Text] [Related]
32. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer].
Xu DK; Zhang XM; Zhao P; Cai JC; Zhao D; Tan W; Guo YL; Lin DX
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1961-5. PubMed ID: 19062735
[TBL] [Abstract][Full Text] [Related]
33. The endothelial nitric oxide synthase gene -786T/C polymorphism is a predictive factor for reattacks of coronary spasm.
Nishijima T; Nakayama M; Yoshimura M; Abe K; Yamamuro M; Suzuki S; Shono M; Sugiyama S; Saito Y; Miyamoto Y; Nakao K; Yasue H; Ogawa H
Pharmacogenet Genomics; 2007 Aug; 17(8):581-7. PubMed ID: 17622934
[TBL] [Abstract][Full Text] [Related]
34. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
[TBL] [Abstract][Full Text] [Related]
35. The influence of Nos3 polymorphisms on age at menarche and natural menopause.
Worda C; Walch K; Sator M; Eppel W; Tempfer CB; Schneeberger C; Huber JC; Hefler LA
Maturitas; 2004 Oct; 49(2):157-62. PubMed ID: 15474760
[TBL] [Abstract][Full Text] [Related]
36. [New polymorphisms in the PSA promoter in patients with prostate carcinoma].
Schostak M; Braun C; Krause H; Miller K; Kempkensteffen C; Hinz S; Strenziok R; Blana A; Schrader M
Aktuelle Urol; 2007 Nov; 38(6):465-72. PubMed ID: 17987534
[TBL] [Abstract][Full Text] [Related]
37. Common genetic variation at the endothelial nitric oxide synthase locus and relations to brachial artery vasodilator function in the community.
Kathiresan S; Larson MG; Vasan RS; Guo CY; Vita JA; Mitchell GF; Keyes MJ; Newton-Cheh C; Musone SL; Lochner AL; Drake JA; Levy D; O'Donnell CJ; Hirschhorn JN; Benjamin EJ
Circulation; 2005 Sep; 112(10):1419-27. PubMed ID: 16129794
[TBL] [Abstract][Full Text] [Related]
38. Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.
Ritt M; Ott C; Delles C; Schneider MP; Schmieder RE
Pharmacogenet Genomics; 2008 Aug; 18(8):699-707. PubMed ID: 18622262
[TBL] [Abstract][Full Text] [Related]
39. Mutational analysis of ETV6 in prostate carcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
Prostate; 2002 Sep; 52(4):305-10. PubMed ID: 12210491
[TBL] [Abstract][Full Text] [Related]
40. Haplotypes, loss of heterozygosity, and expression levels of glycine N-methyltransferase in prostate cancer.
Huang YC; Lee CM; Chen M; Chung MY; Chang YH; Huang WJ; Ho DM; Pan CC; Wu TT; Yang S; Lin MW; Hsieh JT; Chen YM
Clin Cancer Res; 2007 Mar; 13(5):1412-20. PubMed ID: 17332283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
